--

Department of Defense: 

  • Ovarian Cancer Omics Consortium Development Award: The OCRP Pilot Award supports the exploration of innovative concepts or theories in ovarian cancer that could ultimately lead to critical discoveries or major advancements that will drive the field forward. The proposed research must demonstrate a clear focus on ovarian cancer (e.g., using tissues, cell lines, datasets, or appropriate animal models). The proposed research should include a testable hypothesis based on strong scientific rationale and serve as a catalyst to expand or modify current thinking about and/or approaches in ovarian cancer. Includes optional nested Early-Career Investigator award for projects involving clinical trials only (<3 years from last postdoctoral research position). Budget: Up to $400,000 for up to two years. Pre-Application Submission Deadline: July 25, 2018 by 5 p.m. ET. Application Submission Deadline: August 8, 2018 by 11:59 p.m. ET. 
  • Ovarian Cancer Clinical Development Award: The OCRP Clinical Development Award is intended to provide support for the translation of promising preclinical findings into products for clinical applications, including prevention, detection, diagnosis, treatment, or quality of life. The goal of this award mechanism is to accelerate the clinical introduction of medical products and technologies that target ovarian cancer biology. Near-term clinical impact is expected--no pre-clinical animal studies. Includes optional nested Early-Career Investigator award for projects involving clinical trials only (<5 years from last postdoctoral research position). Budget: Up to $600,000 ($800,000 for early career) for up to three years. Pre-Application Submission Deadline: July 25, 2018 by 5 p.m. ET. Application Submission Deadline: August 8, 2018 by 11:59 p.m. ET. 
  • Ovarian Cancer Academy – Early-Career Investigator Award: The OCRP Ovarian Cancer Academy is a unique, interactive virtual academy providing intensive mentoring, national networking, and a peer group for junior faculty. The overarching goal of the Ovarian Cancer Academy is to develop successful, highly productive ovarian cancer researchers in a collaborative research and career development environment. This award mechanism enables the Early-Career Investigator to pursue an ovarian cancer project that may be basic, translational, and/or clinical research, under the guidance of a Designated Mentor. Budget: Up to $725,000 for up to four years.  Pre-Application Submission Deadline: July 25, 2018 by 5 p.m. ET. Application Submission Deadline: August 8, 2018 by 11:59 p.m. ET. 
  • Kidney Cancer, Translational Research Partnership Award: Supports partnerships between clinicians and laboratory scientists that accelerate ideas in kidney cancer into clinical applications. Supports translational correlative studies. Preliminary data required. Clinical trials are not allowed. Budget: up to $600,000 total direct costs for up to three years. Deadline: LOI due September 5, 2018; Full application due September 26, 2018. 
  • Peer Reviewed Cancer Research Program -- Career Development Award: This program supports independent, early-career investigators to conduct impactful research with the guidance of an experienced cancer researcher (i.e., the Career Guide). The Career Development Award presents an opportunity for early-career investigators to obtain the funding, guidance, and experience necessary for productive, independent careers at the forefront of cancer research. This award supports impactful research projects with an emphasis on discovery. Under this award mechanism, the early-career investigator is considered the PI, and the application should focus on the PI’s research and career development. It should be clear that the proposed research is intellectually designed by the PI and not a product of the Career Guide. Preliminary data are not required. However, logical reasoning and a sound scientific rationale for the proposed research must be demonstrated. Budget: Up to $360,000 for 3 years. Pre-Application Submission Deadline: August 28, 2018; Application Submission Deadline: September 26, 2018. 

National Institutes of Health: 

  • Basic and Translational Research on Decision Making in Aging and Alzheimer's Disease: This FOA invites applications for basic research to better characterize the affective, cognitive, social, and motivational parameters of impaired and intact decision making in both normal aging and Alzheimer's disease (AD). Research is sought that will characterize the extent to which basic behavioral and neural processes involved in decision making are differentially impacted in normal aging and AD, investigate the influence of social factors on decision making, and investigate the decision-making factors that render older adults (with or without cognitive impairment) vulnerable to financial exploitation and other forms of mistreatment and abuse. The FOA also invites applications to apply basic research on the processes involved in decision making to the design of decision-supportive interventions for midlife and older adults with and without AD. Specific opportunities include the development of decision-supportive interventions to leverage cognitive, emotional and motivational strengths of these populations; tools to assess decisional capacity; strategies for simplifying choices and offering better defaults; and the promotion of timely adoption of optimal delegation practices (e.g., power of attorney, living wells, etc.). Deadlines: February 8, 2019; June 8, 2019; February 20, 2020; and June 8, 2020.
  • Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 - Independent Clinical Trial Required):  The purpose of the Pathway to Independence Award in Tobacco Regulatory Research (K99/R00) is to increase and maintain a strong cohort of new and talented independent investigators conducting research that will inform the development and evaluation of regulations on tobacco product manufacturing, distribution, and marketing. This program is designed to facilitate a timely transition of outstanding postdoctoral researchers with a research and/or clinical doctorate degree from mentored, postdoctoral research positions to independent, tenure-track or equivalent faculty positions. This program will provide independent research support during this transition in order to help awardees launch competitive, independent research careers. LOI Deadline: For the first round, because of the application due date, the LOIs are due 30 days prior to the first application date. Subsequent LOI due dates are due 60 days prior to the application due date. Application Due Dates: July 19, 2018, November 8, 2018, July 19, 2019, November 8, 2019 , by 5 p.m. local time of applicant organization. 
  • Mentored Research Scientist Career Development Award in Tobacco Regulatory Research (K01 - Independent Clinical Trial Required) & (K01 - Independent Clinical Trial Not Allowed):  The purpose of the Mentored Research Scientist Career Development Award in Tobacco Regulatory Research (K01) is to provide support and protected time (three, four, or five years) for an intensive, supervised career development experience in biomedical, behavioral, and social science research that will inform the development and evaluation of regulations on tobacco product manufacturing, distribution, and marketing and that will lead to research independence. Research projects must address the research priorities related to the regulatory authority of the Food and Drug Administration (FDA) Center for Tobacco Products (CTP) as mandated by the Family Smoking Prevention and Tobacco Control Act (FSPTCA), Public Law 111-31. The awards under this FOA will be administered by NIH using funds made available through the CTP and the FSPTCA (P.L. 111-31). LOI Deadline: For the first round, because of the application due date, the LOIs are due 30 days prior to the first application date. Subsequent  LOI due date is 60 days prior to the application due date. Application Due Dates: July 19, 2018, November 8, 2018, July 19, 2019, November 8, 2019, by 5:00 PM local time of applicant organization. 
  • NIH Director's New Innovator Award Program: The NIH Director's New Innovator Award addresses two important goals: stimulating highly innovative research and supporting promising new investigators. New investigators may have exceptionally innovative research ideas, but not the preliminary data required to fare well in the traditional NIH peer review system. As part of NIH's commitment to increasing opportunities for new scientists,this award supports exceptionally creative new investigators who propose highly innovative research projects that have the potential for unusually high impact. Budget: up to $300,000 per year for up to five years. Deadline: September 10, 2018. 
  • NIH Director's Pioneer Award (DP1 - Clinical Trial Optional): The NIH Director’s Pioneer Award supports individual scientists of exceptional creativity who propose highly innovative and potentially transformative approaches to major challenges in the biomedical or behavioral sciences towards the goal of enhancing human health. Applications from individuals with diverse backgrounds and in any topic relevant to the broad mission of NIH are welcome. To be considered pioneering, the proposed research must reflect substantially different scientific directions from those already being pursued in the investigator’s research program or elsewhere. The NIH Director’s Pioneer Award is a component of the High-Risk, High-Reward Research program of the NIH Common Fund. Up to $700K/year in direct costs. Up to 5 years. Deadline: September 14, 2018. 
  • Maximizing Investigators' Research Award for Early Stage Investigators (R35): The grant will provide support for the program of research in an early stage investigator's laboratory that falls within the mission of NIGMS. For the purpose of this FOA, a program of research is the collection of projects in the investigator's lab that are relevant to the mission of NIGMS. Budget: Applications may request up to $250,000 in direct costs per year for a maximum project period of five years. Applications due October 3, 2018; and October 3, 2019 by 5 p.m. local time of applicant organization. 
  • Roybal Centers for Translational Research on Aging: The purpose of the Roybal Centers is to develop behavioral interventions that improve the health and well-being of people as they are aging and the capacity of institutions to adapt to societal aging. Roybal Centers will conduct Stage 0 through IV pilot studies in accordance with the multidirectional, translational NIH Stage Model, to produce potent and implementable principle-driven behavioral interventions. For the purposes of this FOA, Stage I studies and small-scale Stage 0, II, III, and IV studies will be referred to as "pilot" studies. All applications must include Stage I studies, in which a principle-driven intervention and the intervention's associated materials are created, refined, adapted, and pilot tested for feasibility, acceptability and efficacy. Budget: up to to $500,000 in first-year direct costs for up to five years. Deadline: Optional LOI due September 18, 2018; Full application due October 18, 2018.

 The Carney Institute for Brain Science COBRE Center for Nervous System Function (CNSF):

  • The CNSF aims to increase the quantity and quality of research on the nervous system in Rhode Island. One means of attaining this goal concerns identifying and nurturing talented young investigators and enabling established investigators to create a new research line. The CNSF announces the availability of two,12-month grants of up to $40,000 for research related to nervous system function, pending funding of our Phase II COBRE. The CNSF particularly welcomes projects that explore the neural basis of attention, decision-making, learning, memory, or other cognitive functions. Deadline: August 1, 2018 at 5 p.m. See the RFA

Society for Academic Emergency Medicine Foundation: 

  • Academy of Women in Academic Emergency Medicine Research Grant: This program supports one early career investigator (fellow, instructor, assistant professor) who wishes to address a research question in line with the core ideology of the Academy of Women in Academic Emergency Medicine. This award is intended to allow for preliminary data collection, analysis or collection of pilot data that will further support greater research endeavors. Applicants can request up to $5,000 to support research materials or research assistant support for one year. Deadline: August 1, 2018.

National Ataxia Foundation

  • Young Investigator Award: One-year grants of $35,000 to encourage young investigators to pursue a career in the field of any form of Ataxia research. Candidates must have attained an MD or PhD degree, and have an appointment as a junior faculty member, senior post-doc or clinical fellow. LOI deadline: August 1, 2018. Full proposal deadline: September 4, 2018.

PhRMA Foundation

  • Research Starter Grant for Informatics: The goal of the Informatics Research Starter Grants program is to promote development and use of novel informatics in an integrative approach toward understanding normal processes of human biology and disease processes. Informatics awards support career development of scientists engaged in research that significantly integrates state-of-the-art information technology developed with advanced biological, chemical, and pharmacological sciences. Funding: $100,000 for one year. Deadline: September 1, 2018 at 11:59 p.m. EDT. 
  • Research Starter Grant for Pharmaceutics: This award offers financial support to individuals beginning independent research careers in pharmaceutics (including basic pharmaceutics, biopharmaceutics, pharmaceutical technology, and pharmaceutical biotechnology) at the faculty level. Funding: $100,000 for one year. Deadline: September 1, 2018 at 11:59 p.m. EDT. 
  • Research Starter Grant for Pharmacology / Toxicology: This award intends to encourage multidisciplinary training to apply the perspective of molecular, cell, and systems biology to pharmacology and toxicology research. Their scope includes basic drug action studies, detection of cellular responses to drugs at the gene level that create opportunities to optimize individualized drug therapy, and the corresponding evaluation of pharmaceuticals in human and clinical populations. This award assists individuals beginning independent research careers at the faculty level. Funding: $100,000 for one year. Deadline: September 1, 2018 at 11:59 p.m. EDT. 
  • Research Starter Grant for Translational Medicine and Therapeutics: Translational Medicine and Therapeutics awards will advance training and support career development of scientists engaged in research that significantly addresses specific clinician-defined problems and integrates innovative technologies with advanced biological, chemical, and pharmacological sciences and engineering methodologies. This award assists individuals beginning independent research careers in translational medicine and therapeutics at the faculty level. Funding: $100,000 for one year. Deadline: September 1, 2018 at 11:59 p.m. EDT. 

National Science Foundation

  • Engineering of Biomedical Systems Program: This program provides research opportunities to develop novel ideas into discovery-level and transformative projects that integrate engineering and life sciences in solving biomedical problems that serve humanity in the long-term. EBMS projects must be at the interface of engineering and biomedical sciences and include objectives that advance both engineering and biomedical sciences. Budget:  Generally 1-3 years. Typical award size is $100K/year with allowance for up to $200K/year for collaborative projects or those involving investigators from multiple institutions. Deadline:  October 20, 2018. 

National Institute of Allergy and Infectious Diseases (NIAID): 

  • Physician-Scientist Pathway to Independence Award (K99/R00): This program is designed to facilitate a timely transition of outstanding postdoctoral researchers with a clinical doctorate degree from mentored, postdoctoral research positions to independent, tenure-track or equivalent faculty positions. The program will provide independent NIAID research support during this transition to help awardees launch competitive, independent research careers in biomedical fields and thereby help to address the national physician-scientist workforce shortage. Deadlines: NIH’s Standard Due Dates and Standard AIDS Dates apply.

Diabetes Research & Wellness Foundation: 

  • Research applications related to finding the cause, prevention, treatment, and cure of diabetes and its complications. Applications accepted year-round. 

US Army Medical and Materiel Command’s (USAMRMC):

  • FY18-FY22 BAA for Extramural Medical Research: To study a variety of science & medical topics that provide solutions to medical problems of importance to the American Service member at home and abroad, as well as to the general public at large. Award Amount: not specified; award Duration: 2-5 years. LOIs Due: required, but no deadline; full proposals duerolling through September 30, 2022. 

Online Partnership to Accelerate Research: 

  • Leidos Health has partnered with NIH to accelerate the biomedical research and development enterprise by matching high-scoring (e.g., those within the 30th percentile), unfunded NIH applications with private biomedical foundations and/or industries seeking to fund promising research via OnPAR. Learn more.

National Institutes of Health & Department of Health and Human Services:

University of Vermont I-Trep Program: